NeoGraph Analytics
Medical DevicesNorth America2023 – 2032

Global United States Wearable Medical Devices Market Analysis, Opportunities and Forecast 2024-2032

US wearable medical devices market valued at USD 38.5B in 2023, projected to reach USD 139.7B by 2032 at 15.4% CAGR.

Revenue, 2023

$38.5B

Forecast, 2032

$139.7B

CAGR, 2024-2032

15.4%

Report Coverage

North America

Code: united-states-wearable-medical-devices-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The US wearable medical devices market was valued at USD 38.5 billion in 2023 and is projected to reach USD 139.7 billion by 2032, growing at a 15.4% CAGR. Key growth drivers include rising chronic disease prevalence, FDA-friendly regulatory pathways, and rapid adoption of continuous glucose monitors and smartwatches with clinical-grade biosensors. Abbott, Medtronic, and Apple lead the competitive landscape. Investment opportunities are strongest in AI-enabled remote monitoring and next-generation CGM platforms.

02

Key Highlights

1

CGM devices lead growth, driven by rising diabetes prevalence and Abbott's FreeStyle Libre franchise expansion across the US.

2

Apple Watch and Samsung Galaxy Watch blur consumer-clinical boundaries, accelerating remote patient monitoring adoption nationwide.

3

FDA's evolving digital health framework enables faster wearable approvals, boosting innovation and reducing time-to-market.

03

Market Overview

Market Context

The US wearable medical devices market is in a high-growth phase, fueled by chronic disease burden, telehealth expansion, and consumer health awareness. Continuous glucose monitors and smartwatch biosensors are the primary growth engines.

The US wearable medical devices market is experiencing high growth driven by an aging population, rising diabetes and cardiovascular disease rates, and increasing consumer adoption of health-tracking wearables. The market is transitioning from hospital-centric to consumer-clinic hybrid models.

Market Stage

High growth

Adoption Level

Growing

Key Trends

AI-powered predictive analytics integrated into wearable biosensorsContinuous glucose monitors becoming the fastest-growing segmentSmartwatch ECG and blood oxygen features gaining clinical validationExpansion of remote patient monitoring reimbursement policies
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 15.4%

Base Year (2023)

$38.5B

Forecast (2032)

$139.7B

CAGR (2024-2032)

15.4%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$38.50B
2024$44.43B
2025$51.27B
2026$59.17B
2027$68.28B
2028$78.79B
2029$90.93B
2030$104.93B
2031$121.09B
2032$139.74B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

At a 15.4% CAGR, the market is projected to reach USD 139.7 billion by 2032 from USD 38.5 billion in 2023. CGM and cardiac monitoring segments will drive the majority of incremental revenue growth.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
North America40.0%16.2%United States
Europe30.0%13.8%Germany
Asia Pacific30.0%18.5%China

North America

#1
Share: 40.0%CAGR: 16.2%

Largest market: United States

Europe

#2
Share: 30.0%CAGR: 13.8%

Largest market: Germany

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Rising prevalence of diabetes and cardiovascular diseases in the US
  • Increasing adoption of remote patient monitoring and telehealth
  • FDA expedited approvals for digital health wearable devices
06

Market Segmentation

By Type
Market share distribution across 5 segments
By Type — market share by segment, in percent.
SegmentShare
Vital Signs Monitoring DevicesBlood pressure, heart rate, and SpO2 monitors dominate clinical and consumer wearable device sales.35.0%
Continuous Glucose MonitorsCGM devices are the fastest-growing segment driven by diabetes prevalence and Abbott's FreeStyle Libre.22.0%
Wearable Fitness TrackersConsumer-grade fitness bands and smartwatches increasingly adopted for health monitoring.20.0%
Smart Patches and BiosensorsAdhesive biosensor patches gaining traction for continuous and non-invasive health monitoring.13.0%
Neurological Monitoring DevicesEEG and neurostimulation wearables emerging for epilepsy, depression, and sleep disorder management.10.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
By Application
Market share distribution across 4 segments
By Application — market share by segment, in percent.
SegmentShare
Chronic Disease ManagementDiabetes, cardiovascular, and respiratory disease management represent the largest application segment.40.0%
Remote Patient MonitoringHospital-at-home and post-operative monitoring drive rapid RPM wearable device adoption.25.0%
Fitness and WellnessConsumer wellness tracking remains a significant revenue contributor across all demographics.20.0%
Home HealthcareAging-in-place trends fuel demand for wearable devices enabling independent elderly care at home.15.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Fitness and Wellness Centers
07

Regional Analysis

1

North America

Lead: United States
CAGR: 16.2%Share: 40.0%

North America leads globally due to advanced healthcare infrastructure, high adoption of digital health, and strong reimbursement frameworks.

2

Europe

Lead: Germany
CAGR: 13.8%Share: 30.0%

Europe is driven by aging populations and EU regulatory harmonization enabling faster wearable medical device market entry.

3

Asia Pacific

Lead: China
CAGR: 18.5%Share: 30.0%

Asia Pacific exhibits the highest growth rate, fueled by expanding healthcare access and rising chronic disease burden in China and India.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
United States
42.0%
+16.5%
Germany
14.0%
+13.2%
China
12.0%
+19.8%
08

Competitive Landscape

M

Medtronic plc

Ireland/US

Leader31.7B

Dominates cardiac monitoring and insulin pump wearables with the largest medtech portfolio globally.

The world's largest pure-play medtech company, leading in cardiac rhythm management and insulin pump wearable technologies.

A

Abbott Laboratories

United States

Challenger40.1B

Market leader in continuous glucose monitoring with the FreeStyle Libre franchise driving rapid revenue growth.

A global healthcare leader dominating the continuous glucose monitoring space with its FreeStyle Libre product franchise.

A

Apple Inc.

United States

Disruptor

Consumer health ecosystem leader with FDA-cleared ECG and SpO2 features on Apple Watch accelerating clinical adoption.

Also profiled

K

Koninklijke Philips N.V.

18.2B

A diversified health technology company specializing in hospital-grade wearable biosensors and patient monitoring solutions.

09

Recent Developments

25
2025Apple Inc.

Apple Watch Series 10 receives expanded FDA clearances for sleep apnea detection and advanced atrial fibrillation monitoring.

24
2024Abbott Laboratories

Abbott launches FreeStyle Libre 3 with 60% smaller sensor, real-time continuous glucose readings, and Bluetooth connectivity.

10

Regulatory Landscape

FDA 510(k) premarket notification pathway for Class II wearable medical devicesFDA De Novo classification for novel low-to-moderate risk wearable digital health products
11

Research Methodology

Primary research

  • Expert interviews
  • Surveys

Secondary research

  • Industry reports
  • Company financials

Validation: Triangulation method

12

Strategic Takeaways

Investors

The 15.4% CAGR through 2032 offers strong returns in CGM, cardiac monitoring, and AI-enabled wearable platforms.

Operators

Prioritize AI-driven analytics and remote monitoring integration to capture the fastest-growing market segments.

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.